Stock Earnings Aurinia Pharmaceuticals Inc (AUPH) receives a Buy rating from H.C. Wainwright Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
Insiders Updates AUPH Shares Experience Decline in Value The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Aurinia Pharmaceuticals Inc (AUPH) receives a Buy rating from H.C. Wainwright Aurinia Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on
Stock Earnings AUPH’s short interest shows a sharp rise on 2025-07-15 The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or